GLP-1 based therapies: differential effects on fasting and postprandial glucose
Fineman, M.S., Cirincione, B.B., Maggs, D., Diamant, M.
Published in Diabetes, obesity & metabolism (01.08.2012)
Published in Diabetes, obesity & metabolism (01.08.2012)
Get full text
Journal Article
Initial combination therapy with metformin, pioglitazone and exenatide is more effective than sequential add-on therapy in subjects with new-onset diabetes. Results from the Efficacy and Durability of Initial Combination Therapy for Type 2 Diabetes (EDICT): a randomized trial
Abdul-Ghani, M. A., Puckett, C., Triplitt, C., Maggs, D., Adams, J., Cersosimo, E., DeFronzo, R. A
Published in Diabetes, obesity & metabolism (01.03.2015)
Published in Diabetes, obesity & metabolism (01.03.2015)
Get full text
Journal Article
Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in Type 1 diabetes mellitus: a 1-year, randomized controlled trial
Ratner, R. E., Dickey, R., Fineman, M., Maggs, D. G., Shen, L., Strobel, S. A., Weyer, C., Kolterman, O. G.
Published in Diabetic medicine (01.11.2004)
Published in Diabetic medicine (01.11.2004)
Get full text
Journal Article
Is insulin the most effective injectable antihyperglycaemic therapy?
Buse, J. B., Peters, A., Russell-Jones, D., Furber, S., Donsmark, M., Han, J., MacConell, L., Maggs, D., Diamant, M.
Published in Diabetes, obesity & metabolism (01.02.2015)
Published in Diabetes, obesity & metabolism (01.02.2015)
Get full text
Journal Article
Amylin Replacement With Pramlintide as an Adjunct to Insulin Therapy in Type 1 and Type 2 Diabetes Mellitus: A Physiological Approach Toward Improved Metabolic Control
WEYER, C, MAGGS, D. G, YOUNG, A. A, KOLTERMAN, O. G
Published in Current pharmaceutical design (01.09.2001)
Published in Current pharmaceutical design (01.09.2001)
Get full text
Journal Article
Long-term effects of exenatide therapy over 82 weeks on glycaemic control and weight in over-weight metformin-treated patients with type 2 diabetes mellitus
Ratner, R. E., Maggs, D., Nielsen, L. L., Stonehouse, A. H., Poon, T., Zhang, B., Bicsak, T. A., Brodows, R. G., Kim, D. D.
Published in Diabetes, obesity & metabolism (01.07.2006)
Published in Diabetes, obesity & metabolism (01.07.2006)
Get full text
Journal Article
Feline Epitheliotropic Mastocytic Conjunctivitis in 15 Cats
Beckwith-Cohen, B., Dubielzig, R. R., Maggs, D. J., Teixeira, L. B. C.
Published in Veterinary pathology (01.01.2017)
Published in Veterinary pathology (01.01.2017)
Get full text
Journal Article
Effects of HbA1c and weight reduction on blood pressure in patients with type 2 diabetes mellitus treated with exenatide
Paul, S., Best, J., Klein, K., Han, J., Maggs, D.
Published in Diabetes, obesity & metabolism (01.09.2012)
Published in Diabetes, obesity & metabolism (01.09.2012)
Get full text
Journal Article
Equine keratomycoses in California from 1987 to 2010 (47 cases)
Reed, Z, Thomasy, S M, Good, K L, Maggs, D J, Magdesian, K G, Pusterla, N, Hollingsworth, S R
Published in Equine veterinary journal (01.05.2013)
Published in Equine veterinary journal (01.05.2013)
Get more information
Journal Article
Efficacy and Metabolic Effects of Metformin and Troglitazone in Type II Diabetes Mellitus
Inzucchi, Silvio E, Maggs, David G, Spollett, Geralyn R, Page, Stephanie L, Rife, Frances S, Walton, Veronika, Shulman, Gerald I
Published in The New England journal of medicine (26.03.1998)
Published in The New England journal of medicine (26.03.1998)
Get full text
Journal Article
Adjunctive therapy with pramlintide lowers HbA1c without concomitant weight gain and increased risk of severe hypoglycemia in patients with type 1 diabetes approaching glycemic targets
Ratner, R, Whitehouse, F, Fineman, M S, Strobel, S, Shen, L, Maggs, D G, Kolterman, O G, Weyer, C
Published in Experimental and clinical endocrinology & diabetes (01.04.2005)
Published in Experimental and clinical endocrinology & diabetes (01.04.2005)
Get more information
Journal Article
Cardiovascular outcomes associated with a new once-weekly GLP-1 receptor agonist vs. traditional therapies for type 2 diabetes: a simulation analysis
Peskin, B. R., Shcheprov, A. V., Boye, K. S., Bruce, S., Maggs, D. G., Gaebler, J. A.
Published in Diabetes, obesity & metabolism (01.10.2011)
Published in Diabetes, obesity & metabolism (01.10.2011)
Get full text
Journal Article
Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial
Maggs, D G, Buchanan, T A, Burant, C F, Cline, G, Gumbiner, B, Hsueh, W A, Inzucchi, S, Kelley, D, Nolan, J, Olefsky, J M, Polonsky, K S, Silver, D, Valiquett, T R, Shulman, G I
Published in Annals of internal medicine (01.02.1998)
Published in Annals of internal medicine (01.02.1998)
Get more information
Journal Article
Effect of pramlintide on A1C and body weight in insulin-treated African Americans and Hispanics with type 2 diabetes: A pooled post hoc analysis
MAGGS, D, SHEN, L, STROBEL, S, BROWN, D, KOLTERMAN, O, WEYER, C
Published in Metabolism, clinical and experimental (01.12.2003)
Published in Metabolism, clinical and experimental (01.12.2003)
Get full text
Journal Article
PDB11 Glycemic Outcomes Among Patients Receiving Exenatide BID or Liraglutide for Type 2 Diabetes in Clinical Practice: A Retrospective Analysis of the GE Centricity EMR Data
Best, J.H, Wintle, M, Saunders, W.B, DeYoung, M.B, Blickensderfer, A, Maggs, D
Published in Value in health (2011)
Published in Value in health (2011)
Get full text
Journal Article